Publications

Detailed Information

Fragile maintenance of allograft tolerance induced by lymphocyte sequestration and co-stimulation blockade

DC Field Value Language
dc.contributor.authorJin, Jizhe-
dc.contributor.authorYang, Seung Hee-
dc.contributor.authorPark, Junghwan-
dc.contributor.authorLee, Chungsik-
dc.contributor.authorKim, Sun Moon-
dc.contributor.authorKim, Yon Su-
dc.contributor.authorLee, Jungpyo-
dc.date.accessioned2012-05-24T02:38:17Z-
dc.date.available2012-05-24T02:38:17Z-
dc.date.issued2009-09-
dc.identifier.citationTRANSPLANT IMMUNOLOGY; Vol.21 4; 221-227ko_KR
dc.identifier.issn0966-3274-
dc.identifier.urihttps://hdl.handle.net/10371/76390-
dc.description.abstractThe induction of long-term graft survival has been a goal for the last decade. Nevertheless, the issues of stable maintenance of allograft have not yet been evaluated thoroughly. Here, we studied new approaches for induction of tolerance by lymphocyte sequestration (FrY720) and co-stimulatory blockade (MRI) in skin graft model (DBA/2 to BALB/c), thus evaluating the mechanisms incorporated into the maintenance of allograft in proper function. IFTY720 + MR1 treatment significantly prolonged graft survival than single agent treatment did, and induced long-term graft survival in 60% of recipients expressing the up-regulation of IL-4 and FoxP3. To assess the stability of graft maintenance, we performed the second transplantation on recipients that had shown long-term graft survival. While recipients accepted the second graft from the same strain of first donor, the recipients not only rejected the third-party skin (C57BL/6) promptly but also rejected the first graft soon after the third-party skin was transplanted. The expression patterns of IL-4 and FoxP3 were changed according to the strains of second graft in lymph nodes and in the first graft. T(reg) cells from tolerant recipients effectively suppressed allo-antigen driven T cell proliferation, but T(reg) cells from recipients primed with third-party antigen had significantly hampered suppressive capacity against previously tolerant antigens. Our data indicate that the combination treatment provides effective tool for the induction of long-term graft survival, and the maintenance of allograft in proper function is an actively regulated process. (C) 2009 Elsevier B.V. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE BVko_KR
dc.subjectImmunoregulationko_KR
dc.subjectLymphocyte sequestrationko_KR
dc.subjectCo-stimulation blockadeko_KR
dc.subjectLong-term graft survivalko_KR
dc.titleFragile maintenance of allograft tolerance induced by lymphocyte sequestration and co-stimulation blockadeko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor양승희-
dc.contributor.AlternativeAuthor박정환-
dc.contributor.AlternativeAuthor이정식-
dc.contributor.AlternativeAuthor이정표-
dc.contributor.AlternativeAuthor김선문-
dc.contributor.AlternativeAuthor김연수-
dc.identifier.doi10.1016/j.trim.2009.06.001-
dc.citation.journaltitleTRANSPLANT IMMUNOLOGY-
dc.description.citedreferenceGuo K, 2008, TRANSPLANTATION, V85, P93, DOI 10.1097/01.tp.0000296061.71662.76-
dc.description.citedreferenceJee Y, 2007, CLIN IMMUNOL, V125, P34, DOI 10.1016/j.clim.2007.05.020-
dc.description.citedreferenceBoschiero L, 2007, TRANSPL P, V39, P2013-
dc.description.citedreferenceKang SM, 2007, AM J TRANSPLANT, V7, P1457, DOI 10.1111/j.1600-6143.2007.01829.x-
dc.description.citedreferencePlain KM, 2007, TRANSPLANTATION, V83, P764, DOI 10.1097/01.tp.0000256326.11647.2e-
dc.description.citedreferenceJiang SP, 2006, TRANSPLANTATION, V82, P1738, DOI 10.1097/01.tp.0000244932.29542.9e-
dc.description.citedreferenceWang Y, 2006, AM J TRANSPLANT, V6, P2851, DOI 10.1111/j.1600-6143.2006.01550.x-
dc.description.citedreferenceChattopadhyay K, 2006, J IMMUNOL, V177, P3920-
dc.description.citedreferenceRudensky AY, 2006, CELL, V126, P253, DOI 10.1016/j.cell.2006.07.005-
dc.description.citedreferenceZhai YA, 2006, J IMMUNOL, V176, P5988-
dc.description.citedreferenceKaplan B, 2006, AM J KIDNEY DIS, V47, pS52, DOI 10.1053/j.ajkd.2005.12.044-
dc.description.citedreferenceIsoyama N, 2006, TRANSPL IMMUNOL, V15, P265, DOI 10.1016/j.trim.2006.02.004-
dc.description.citedreferenceCHIBA K, 2006, CELL MOL IMMUNOL, V3, P11-
dc.description.citedreferenceSawicka E, 2005, J IMMUNOL, V175, P7973-
dc.description.citedreferenceWing K, 2005, IMMUNOLOGY, V115, P516, DOI 10.1111/j.1365-2567.2005.02186.x-
dc.description.citedreferenceWang WG, 2005, FASEB J, V19, P1731, DOI 10.1096/fj.05-3730fje-
dc.description.citedreferenceYan S, 2005, TRANSPLANTATION, V79, P1703, DOI 10.1097/01.TP.0000164501.65352.39-
dc.description.citedreferenceKarim M, 2005, BLOOD, V105, P4871, DOI 10.1182/blood-2004-10-3888-
dc.description.citedreferenceFontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179-
dc.description.citedreferenceWalsh PT, 2004, J CLIN INVEST, V114, P1398, DOI 10.1172/JCI200423238-
dc.description.citedreferenceTanchot C, 2004, J IMMUNOL, V172, P4285-
dc.description.citedreferencevan Maurik A, 2004, J IMMUNOL, V172, P2163-
dc.description.citedreferenceAbdi R, 2004, J IMMUNOL, V172, P767-
dc.description.citedreferenceWang MH, 2003, ACTA PHARMACOL SIN, V24, P847-
dc.description.citedreferenceFontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904-
dc.description.citedreferenceXie JH, 2003, J IMMUNOL, V170, P3662-
dc.description.citedreferenceHori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490-
dc.description.citedreferenceBrinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C220176200-
dc.description.citedreferenceHori S, 2002, P NATL ACAD SCI USA, V99, P8213, DOI 10.1073/pnas.122224799-
dc.description.citedreferenceWeiner HL, 2001, IMMUNOL REV, V182, P207-
dc.description.citedreferenceHe XY, 2001, TRANSPLANT P, V33, P703-
dc.description.citedreferenceWONDIMU B, 2001, INT J PAEDIATR DENT, V11, P424-
dc.description.citedreferencePOHANKA E, 2001, CURR OPIN UROL, V11, P143-
dc.description.citedreferenceThornton AM, 2000, J IMMUNOL, V164, P183-
dc.description.citedreferenceFujiwara I, 1999, TRANSPLANT P, V31, P2831-
dc.description.citedreferenceHwang MW, 1999, CIRCULATION, V100, P1322-
dc.description.citedreferenceItoh M, 1999, J IMMUNOL, V162, P5317-
dc.description.citedreferenceSayegh MH, 1998, NEW ENGL J MED, V338, P1813-
dc.description.citedreferenceOnodera K, 1997, J IMMUNOL, V158, P1572-
dc.description.citedreferenceMACDONALD HR, 1988, J EXP MED, V167, P2005-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share